07.06.2013 Views

Docetaxel with prednisone or prednisolone for the treatment of ...

Docetaxel with prednisone or prednisolone for the treatment of ...

Docetaxel with prednisone or prednisolone for the treatment of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

110<br />

Appendix 1<br />

6. (serotron OR pralifan OR “cl 232315”) AND<br />

prostate<br />

7. (dihydroxyanthracenedione) AND prostate<br />

8. (dhad OR “hidrocl<strong>or</strong>uro de mitoxantrona”)<br />

AND prostate<br />

9. (“mitoxantroni hydrochl<strong>or</strong>idum”) AND<br />

prostate<br />

10. (“mitrozantrone hydrochl<strong>or</strong>ide”) AND prostate<br />

11. (“nsc 301739” OR “65271 80 9”) AND prostate<br />

12. (“70476 82 3” OR “l01db07”) AND prostate<br />

Cost-effectiveness<br />

MEDLINE and MEDLINE In Process<br />

And O<strong>the</strong>r Non-Indexed Citations<br />

(Ovid Online – www.ovid.com)<br />

1966 to May week 4, 2005 (MEDLINE) and 2<br />

June 2005 (MEDLINE In Process)<br />

Limits:<br />

● No date limits were applied.<br />

● Animal-only studies were excluded.<br />

● No language limits were applied.<br />

This search retrieved 164 references from<br />

MEDLINE and five from MEDLINE In Process.<br />

1. prostatic neoplasms/<br />

2. ((prostate <strong>or</strong> prostatic) adj2 (neoplasm$ <strong>or</strong><br />

cancer$ <strong>or</strong> carcinoma$ <strong>or</strong> adenocarcinoma$ <strong>or</strong><br />

tumour$ <strong>or</strong> tum<strong>or</strong>$)).ti,ab.<br />

3. 1 <strong>or</strong> 2<br />

4. animal/ not (animal/ and human/)<br />

5. 3 not 4<br />

6. (utilit$ approach$ <strong>or</strong> health gain <strong>or</strong> hui <strong>or</strong><br />

hui2 <strong>or</strong> hui 2 <strong>or</strong> hui3 <strong>or</strong> hui 3).ti,ab.<br />

7. (health measurement$ scale$ <strong>or</strong> health<br />

measurement$ questionnaire$).ti,ab.<br />

8. (standard gamble$ <strong>or</strong> categ<strong>or</strong>$ scal$ <strong>or</strong> linear<br />

scal$ <strong>or</strong> linear analog$ <strong>or</strong> visual scal$ <strong>or</strong><br />

magnitude estimat$).ti,ab.<br />

9. (time trade <strong>of</strong>f$ <strong>or</strong> rosser$ classif$ <strong>or</strong> rosser$<br />

matrix <strong>or</strong> rosser$ distress$ <strong>or</strong> hrqol).ti,ab.<br />

10. (index <strong>of</strong> wellbeing <strong>or</strong> quality <strong>of</strong> wellbeing <strong>or</strong><br />

qwb).ti,ab.<br />

11. (multiattribute$ health ind$ <strong>or</strong> multi<br />

attribute$ health ind$).ti,ab.<br />

12. (health utilit$ index <strong>or</strong> health utilit$<br />

indices).ti,ab.<br />

13. (multiattribute$ <strong>the</strong><strong>or</strong>$ <strong>or</strong> multi attribute$<br />

<strong>the</strong><strong>or</strong>$ <strong>or</strong> multiattribute$ analys$ <strong>or</strong> multi<br />

attribute$ analys$).ti,ab.<br />

14. (health utilit$ scale$ <strong>or</strong> classification <strong>of</strong> illness<br />

state$ <strong>or</strong> 15 dimension).ti,ab.<br />

15. health state$ utilit$.ti,ab.<br />

16. well year$.ti,ab.<br />

17. (multiattribute$ utilit$ <strong>or</strong> multi attribute$<br />

utilit$).ti,ab.<br />

18. health utilit$ scale$.ti,ab.<br />

19. (euro qol <strong>or</strong> euro qual <strong>or</strong> eq-5d <strong>or</strong> eq5d <strong>or</strong> eq<br />

5d <strong>or</strong> euroqol <strong>or</strong> euroqual).ti,ab.<br />

20. (qualy <strong>or</strong> qaly <strong>or</strong> qualys <strong>or</strong> qalys <strong>or</strong> quality<br />

adjusted life year$).ti,ab.<br />

21. willingness to pay.ti,ab.<br />

22. (hye <strong>or</strong> hyes <strong>or</strong> health$ year$<br />

equivalent$).ti,ab.<br />

23. (person trade <strong>of</strong>f$ <strong>or</strong> person trade<strong>of</strong>f$ <strong>or</strong> time<br />

trade<strong>of</strong>f$ <strong>or</strong> time trade <strong>of</strong>f$).ti,ab.<br />

24. <strong>the</strong><strong>or</strong>y utilit$.ti,ab.<br />

25. (sf36 <strong>or</strong> sf 36).ti,ab.<br />

26. (sh<strong>or</strong>t f<strong>or</strong>m 36 <strong>or</strong> sh<strong>or</strong>tf<strong>or</strong>m 36 <strong>or</strong> sf thirtysix<br />

<strong>or</strong> sf thirty six <strong>or</strong> sh<strong>or</strong>tf<strong>or</strong>m thirtysix <strong>or</strong><br />

sh<strong>or</strong>tf<strong>or</strong>m thirty six <strong>or</strong> sh<strong>or</strong>t f<strong>or</strong>m thirtysix <strong>or</strong><br />

sh<strong>or</strong>t f<strong>or</strong>m thirty six).ti,ab.<br />

27. (sf 6d <strong>or</strong> sh<strong>or</strong>t from 6d).ti,ab.<br />

28. <strong>or</strong>/6-27<br />

29. 28 and 5<br />

30. letter.pt.<br />

31. edit<strong>or</strong>ial.pt.<br />

32. comment.pt.<br />

33. <strong>or</strong>/30-32<br />

34. 29 not 33<br />

EMBASE (OVID Online –<br />

http://www.ovid.com/)<br />

1980 to 2005 week 22.<br />

Limits:<br />

● No date limits were applied.<br />

● Animal-only studies were excluded.<br />

● No language limits were applied.<br />

This search retrieved 143 references.<br />

1. Prostatic Intraepi<strong>the</strong>lial Neoplasia/<br />

2. ((prostate <strong>or</strong> prostatic) adj2 (neoplasm$ <strong>or</strong><br />

cancer$ <strong>or</strong> carcinoma$ <strong>or</strong> adenocarcinoma$ <strong>or</strong><br />

tumour$ <strong>or</strong> tum<strong>or</strong>$)).ti,ab.<br />

3. 1 <strong>or</strong> 2<br />

4. animal/ not (animal/ and human/)<br />

5. 3 not 4<br />

6. (utilit$ approach$ <strong>or</strong> health gain <strong>or</strong> hui <strong>or</strong><br />

hui2 <strong>or</strong> hui 2 <strong>or</strong> hui3 <strong>or</strong> hui 3).ti,ab.<br />

7. (health measurement$ scale$ <strong>or</strong> health<br />

measurement$ questionnaire$).ti,ab.<br />

8. (standard gamble$ <strong>or</strong> categ<strong>or</strong>$ scal$ <strong>or</strong> linear<br />

scal$ <strong>or</strong> linear analog$ <strong>or</strong> visual scal$ <strong>or</strong><br />

magnitude estimat$).ti,ab.<br />

9. (time trade <strong>of</strong>f$ <strong>or</strong> rosser$ classif$ <strong>or</strong><br />

rosser$ matrix <strong>or</strong> rosser$ distress$ <strong>or</strong><br />

hrqol).ti,ab.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!